BACKGROUND: We tested the feasibility of targeted left ventricular (LV) mural injection using real-time MRI (rtMRI). METHODS AND RESULTS: A 1.5T MRI scanner was customized with a fast reconstruction engine, transfemoral guiding catheter-receiver coil (GCC), MRI-compatible needle, and tableside consoles. Commercial real-time imaging software was customized to facilitate catheter navigation and visualization of injections at 4 completely refreshed frames per second. The aorta was traversed and the left ventricular cavity was entered under direct rtMRI guidance. Pigs underwent multiple injections with dilute gadolinium-DTPA. All myocardial segments were readily accessed. The active GCC and the passive Stiletto needle injector were readily visualized. More than 50 endomyocardial injections were performed with the aid of rtMRI; 81% were successful with this first-generation prototype. CONCLUSION: Percutaneous endomyocardial drug delivery is feasible with the aid of rtMRI, which permits precise 3-dimensional localization of injection within the LV wall.
BACKGROUND: We tested the feasibility of targeted left ventricular (LV) mural injection using real-time MRI (rtMRI). METHODS AND RESULTS: A 1.5T MRI scanner was customized with a fast reconstruction engine, transfemoral guiding catheter-receiver coil (GCC), MRI-compatible needle, and tableside consoles. Commercial real-time imaging software was customized to facilitate catheter navigation and visualization of injections at 4 completely refreshed frames per second. The aorta was traversed and the left ventricular cavity was entered under direct rtMRI guidance. Pigs underwent multiple injections with dilute gadolinium-DTPA. All myocardial segments were readily accessed. The active GCC and the passive Stiletto needle injector were readily visualized. More than 50 endomyocardial injections were performed with the aid of rtMRI; 81% were successful with this first-generation prototype. CONCLUSION: Percutaneous endomyocardial drug delivery is feasible with the aid of rtMRI, which permits precise 3-dimensional localization of injection within the LV wall.
Authors: J M Serfaty; E Atalar; J Declerck; P Karmakar; H H Quick; K A Shunk; A W Heldman; X Yang Journal: Radiology Date: 2000-10 Impact factor: 11.105
Authors: R A Omary; O Unal; D S Koscielski; R Frayne; F R Korosec; C A Mistretta; C M Strother; T M Grist Journal: J Vasc Interv Radiol Date: 2000-09 Impact factor: 3.464
Authors: R A Omary; R Frayne; O Unal; T Warner; F R Korosec; C A Mistretta; C M Strother; T M Grist Journal: J Vasc Interv Radiol Date: 2000-03 Impact factor: 3.464
Authors: Matthew O'Donnell; Elliot R McVeigh; H William Strauss; Atsushi Tanaka; Brett E Bouma; Guillermo J Tearney; Michael A Guttman; Ernest V Garcia Journal: J Nucl Med Date: 2010-05-01 Impact factor: 10.057
Authors: Dana C Peters; Robert J Lederman; Alexander J Dick; Venkatesh K Raman; Michael A Guttman; J Andrew Derbyshire; Elliot R McVeigh Journal: Magn Reson Med Date: 2003-02 Impact factor: 4.668
Authors: Michael A Guttman; Peter Kellman; Alexander J Dick; Robert J Lederman; Elliot R McVeigh Journal: Magn Reson Med Date: 2003-08 Impact factor: 4.668
Authors: Robert C Susil; Axel Krieger; J Andrew Derbyshire; Attila Tanacs; Louis L Whitcomb; Gabor Fichtinger; Ergin Atalar Journal: Radiology Date: 2003-09 Impact factor: 11.105
Authors: Jonathan M Hill; Alexander J Dick; Venkatesh K Raman; Richard B Thompson; Zu-Xi Yu; K Allison Hinds; Breno S S Pessanha; Michael A Guttman; Timothy R Varney; Bradley J Martin; Cynthia E Dunbar; Elliot R McVeigh; Robert J Lederman Journal: Circulation Date: 2003-08-11 Impact factor: 29.690